Evaluating the Transition From Pediatric to Adult Care Among Adolescents With Chronic Granulomatous Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

33 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-03-26

Study Completion Date

2017-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background:

People who get chronic illnesses as children are living longer. When they turn 18, they switch from pediatric care to adult care. This can be a difficult change. Chronic Granulomatous Disease (CGD) is an inherited disease. It causes long-term, repeated infections. People with CGD are usually diagnosed when they are very young children. Researchers want to find out more about how young people with CGD handle the change to adult care. What they learn may make this easier for people with CGD in the future.

Objective:

\- To identify what helped or hurt young adults with CGD as they went from pediatric to adult care.

Eligibility:

\- Adults with CGD who were 18 24 years old between January 2011 and February 2014.

Design:

* Participants will already be enrolled in NIH studies.
* Eligible people will get materials in the mail. They will get a letter with study information, an interview questionnaire, and an information sheet.
* Researchers will call participants 1 week after the packets are sent. They will talk about the study and find out if the person wants to join.
* An interview will be completed immediately or scheduled for the future. The interview will take about 45 minutes. The researcher will ask the participant about their disease. They will also ask about travel to NIH, being an outpatient or inpatient there, and legal documents.
* Researchers may contact the subjects again by phone if they need more information at any point during the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995

NCT02116764

Chronic Granulomatous Disease

COMPLETED

Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of Care

NCT00023192

Chronic Granulomatous Disease

COMPLETED PHASE3

Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995

NCT02082353

Granulomatous Disease, Chronic

UNKNOWN

Learning and Behavior Problems in Children With Chronic Granulomatous Disease and Related Disorders

NCT00005933

Chediak Higashi Syndrome Chronic Granulomatous Disease Job's Syndrome +1 more

COMPLETED

Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease

NCT02234934

Granulomatous Disease, Chronic, X-linked

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Children with chronic illnesses are thriving well into adulthood due to ongoing medical advances. Many healthy and typically developing 18-year-olds should be able to manage a transition from pediatric to adult care, but this transition can be challenging for adolescents with chronic illness. A poor transition to adult care can result in medical, social and educational issues for patients, families and the medical team. At issue are questions of independence and self-management: are young adult patients prepared to travel to NIH alone? Are they prepared to speak with physicians about their disease process and medications? Are they ready to give informed consent for studies in which they have been participating?

The National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) has several hundred adolescents enrolled in clinical trials, many of whom rely on NIH providers for specialized care. No formal program exists to assist these patients in the transition from pediatric to adult care. Pediatric inpatients are admitted to the adult inpatient unit when they turn 18 with little knowledge of the policy differences between the units.

The investigators propose a retrospective exploratory descriptive study to (a) identify and describe experiences that young adults found to enable or hinder their transition and (b) explore these patients ideas for enhancing the transition process. A semi-structured questionnaire administered by phone or face to face to approximately 40 young adults with chronic granulomatous disease (CGD) will gather qualitative and quantitative information about the use of inpatient and outpatient services at the NIH Clinical Center prior to and since the subjects 18th birthdays. Data will be used to develop a program to help NIAID pediatric patients with CGD transition successfully to adult care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CGD

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. 18 to 24 years of age during January 1, 2011 to December 31, 2012
2. Documented diagnosis of CGD
3. Enrolled in one of the following three NIAID protocols that investigate CGD (and other immunodeficiencies):

* Detection and Characterization of Host Defense Defects (93-I-0119), PI: Dr. Steven Holland
* Screening and Baseline Assessment of Patients with Abnormalities of Immune Function (05-I-0213), PI: Dr. Harry Malech
* Screening Protocol for Detection and Characterization of Infections and Infection (07-I-0033), PI: Dr. Steven Holland
4. Record of a visit to NIH prior to 18th birthday and at least one visit during January 1, 2011 to December 31, 2012
5. Health status sufficient to participate in an interview, as determined by patient self-report at the start of the interview.
6. Fluency in English

Minimum Eligible Age

18 Years

Maximum Eligible Age

26 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No